SBF was ‘very resistant’ to investors on FTX board: Paradigm co-founder
Matt Huang said he was led to believe that Alameda Research was not being provided any special treatment by FTX.
Auto Added by WPeMatico
Auto Added by WPeMatico
Matt Huang said he was led to believe that Alameda Research was not being provided any special treatment by FTX.